TNKASE (tenecteplase) - Roche, Boehringer Ingelheim
Butylphthalide combined with tenecteplase in mild disabling acute ischaemic stroke in China (BENEFIT-2): study protocol for a multicentre, randomised, double-blind, active-controlled trial. (PubMed, BMJ Open) - Sep 9, 2026 - P3 | "Results will be published in peer-reviewed journals and presented at academic conferences. NCT07369999." 
Clinical protocol • Journal • Cardiovascular • Cerebral Hemorrhage • Ischemic stroke
http://www.ncbi.nlm.nih.gov/pubmed/42711080
 
David Wang; Duolao Wang; Le Zhang; Lei Tang; Li Wang; Minxue Shen; Qiaoling Tang; Ran Liu; Sai Wang; Xiangbin Zhang; Ye Li; Yi Zeng
 
Sep 9, 2026
 
Prev Next